NCT04465864View on ClinicalTrials.gov

Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

January 31, 2021

Conditions
Glaucoma, Primary Open AngleCataract
Interventions
DRUG

Intracanalicular Dexamethasone, 0.4 mg insert

Intracanalicular Dexamethasone, 0.4 mg insert four days (+/- 1 day) prior to surgery or inserted the day of surgery.

Trial Locations (1)

90505

Wolstan and Goldberg Eye Associates, Torrance

All Listed Sponsors
lead

Wolstan and Goldberg Eye Associates

NETWORK

NCT04465864 - Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert | Biotech Hunter | Biotech Hunter